137 related articles for article (PubMed ID: 32326065)
21. Enantiomeric composition of natural pericosine A derived from Periconia byssoides and α-glycosidase inhibitory activity of (-)-enantiomer.
Usami Y; Nakamura K; Mizobuchi Y; Mizuki K; Harusawa S; Yoneyama H; Yamada T
Chirality; 2022 Oct; 34(10):1320-1327. PubMed ID: 35775430
[TBL] [Abstract][Full Text] [Related]
22. Quinazolinone derivatives: Synthesis and comparison of inhibitory mechanisms on α-glucosidase.
Wei M; Chai WM; Wang R; Yang Q; Deng Z; Peng Y
Bioorg Med Chem; 2017 Feb; 25(4):1303-1308. PubMed ID: 28110817
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors.
Han K; Li Y; Zhang Y; Teng Y; Ma Y; Wang M; Wang R; Xu W; Yao Q; Zhang Y; Qin H; Sun H; Yu P
Bioorg Med Chem Lett; 2015 Apr; 25(7):1471-5. PubMed ID: 25759031
[TBL] [Abstract][Full Text] [Related]
25. Natural flavonoid α-glucosidase inhibitors from Retama raetam: Enzyme inhibition and molecular docking reveal important interactions with the enzyme active site.
Ghani U; Nur-E-Alam M; Yousaf M; Ul-Haq Z; Noman OM; Al-Rehaily AJ
Bioorg Chem; 2019 Jun; 87():736-742. PubMed ID: 30954838
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of benzothiazole derivatives as a potent α-glucosidase inhibitor.
Gollapalli M; Taha M; Javid MT; Almandil NB; Rahim F; Wadood A; Mosaddik A; Ibrahim M; Alqahtani MA; Bamarouf YA
Bioorg Chem; 2019 Apr; 85():33-48. PubMed ID: 30599411
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of α-glucosidase inhibiting potentials with docking calculations of synthesized arylidene-pyrazolones.
Chaudhry F; Naureen S; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Jahan B; Hyder Khan M; Iqbal F; Ali Munawar M; Ain Khan M
Bioorg Chem; 2018 Apr; 77():507-514. PubMed ID: 29454828
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
Wang G; Chen M; Qiu J; Xie Z; Cao A
Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, molecular docking and α-glucosidase inhibition of 5-aryl-2-(6'-nitrobenzofuran-2'-yl)-1,3,4-oxadiazoles.
Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Saad SM; Khan KM; Nasir A
Bioorg Chem; 2016 Jun; 66():117-23. PubMed ID: 27149363
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, biological evaluation and molecular docking studies of chromone hydrazone derivatives as α-glucosidase inhibitors.
Wang G; Chen M; Wang J; Peng Y; Li L; Xie Z; Deng B; Chen S; Li W
Bioorg Med Chem Lett; 2017 Jul; 27(13):2957-2961. PubMed ID: 28506754
[TBL] [Abstract][Full Text] [Related]
32. Molecular docking studies and synthesis of novel bisbenzimidazole derivatives as inhibitors of α-glucosidase.
Özil M; Emirik M; Beldüz A; Ülker S
Bioorg Med Chem; 2016 Nov; 24(21):5103-5114. PubMed ID: 27576293
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of novel flavone hydrazones: in-vitro evaluation of α-glucosidase inhibition, QSAR analysis and docking studies.
Imran S; Taha M; Ismail NH; Kashif SM; Rahim F; Jamil W; Hariono M; Yusuf M; Wahab H
Eur J Med Chem; 2015 Nov; 105():156-70. PubMed ID: 26491979
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, In Vitro α-Glucosidase Inhibitory Activity and Molecular Docking Studies of Novel Benzothiazole-Triazole Derivatives.
Gong Z; Peng Y; Qiu J; Cao A; Wang G; Peng Z
Molecules; 2017 Sep; 22(9):. PubMed ID: 28914795
[TBL] [Abstract][Full Text] [Related]
35. Syntheses, in vitro α-amylase and α-glucosidase dual inhibitory activities of 4-amino-1,2,4-triazole derivatives their molecular docking and kinetic studies.
Yeye EO; Kanwal ; Mohammed Khan K; Chigurupati S; Wadood A; Ur Rehman A; Perveen S; Kannan Maharajan M; Shamim S; Hameed S; Aboaba SA; Taha M
Bioorg Med Chem; 2020 Jun; 28(11):115467. PubMed ID: 32327353
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
[TBL] [Abstract][Full Text] [Related]
37. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study.
Al-Salahi R; Ahmad R; Anouar E; Iwana Nor Azman NI; Marzouk M; Abuelizz HA
Future Med Chem; 2018 Aug; 10(16):1889-1905. PubMed ID: 29882426
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase.
Peytam F; Takalloobanafshi G; Saadattalab T; Norouzbahari M; Emamgholipour Z; Moghimi S; Firoozpour L; Bijanzadeh HR; Faramarzi MA; Mojtabavi S; Rashidi-Ranjbar P; Karima S; Pakraad R; Foroumadi A
Sci Rep; 2021 Jun; 11(1):11911. PubMed ID: 34099819
[TBL] [Abstract][Full Text] [Related]
39. Celebrex derivatives: Synthesis, α-glucosidase inhibition, crystal structures and molecular docking studies.
Kausar N; Ullah S; Khan MA; Zafar H; Atia-Tul-Wahab ; Choudhary MI; Yousuf S
Bioorg Chem; 2021 Jan; 106():104499. PubMed ID: 33288319
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
